Follow-up of the largest randomized trial of AI in medicine was reported a week ago. The Mammography Screening with Artificial Intelligence trial (MASAI) randomized trial in Sweden of more than 105,000 women compared the interpretation by two radiologists with one radiologist with AI support. This represents the culmination of several years of intensive research exploring the potential role of deep learning AI to improve the accuracy of interpreting mammograms beyond that of radiologists. In thi...